207 related articles for article (PubMed ID: 29182544)
21. A novel RING finger-B box-coiled-coil protein, GERP.
Vincent SR; Kwasnicka DA; Fretier P
Biochem Biophys Res Commun; 2000 Dec; 279(2):482-6. PubMed ID: 11118312
[TBL] [Abstract][Full Text] [Related]
22. Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.
Rocha S; Garrett MD; Campbell KJ; Schumm K; Perkins ND
EMBO J; 2005 Mar; 24(6):1157-69. PubMed ID: 15775976
[TBL] [Abstract][Full Text] [Related]
23. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review).
Van Dyck F; Declercq J; Braem CV; Van de Ven WJ
Int J Oncol; 2007 Apr; 30(4):765-74. PubMed ID: 17332914
[TBL] [Abstract][Full Text] [Related]
24. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
25. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
27. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
[TBL] [Abstract][Full Text] [Related]
28. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.
Yu S; Gao B; Duan Z; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(2):247-51. PubMed ID: 21651891
[TBL] [Abstract][Full Text] [Related]
29. Notch as a tumour suppressor.
Nowell CS; Radtke F
Nat Rev Cancer; 2017 Mar; 17(3):145-159. PubMed ID: 28154375
[TBL] [Abstract][Full Text] [Related]
30. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
31. RING domain is essential for the antiviral activity of TRIM25 from orange spotted grouper.
Yang Y; Huang Y; Yu Y; Yang M; Zhou S; Qin Q; Huang X
Fish Shellfish Immunol; 2016 Aug; 55():304-14. PubMed ID: 27276113
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the p53 gene occur in diverse human tumour types.
Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
[TBL] [Abstract][Full Text] [Related]
33. TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: From muscular dystrophy to tumours.
Lazzari E; Meroni G
Int J Biochem Cell Biol; 2016 Oct; 79():469-477. PubMed ID: 27458054
[TBL] [Abstract][Full Text] [Related]
34. Tuning NF-κB activity: a touch of COMMD proteins.
Bartuzi P; Hofker MH; van de Sluis B
Biochim Biophys Acta; 2013 Dec; 1832(12):2315-21. PubMed ID: 24080195
[TBL] [Abstract][Full Text] [Related]
35. VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells.
Fernández-Martínez AB; Carmena MJ; Bajo AM; Vacas E; Sánchez-Chapado M; Prieto JC
Cell Signal; 2015 Feb; 27(2):236-44. PubMed ID: 25446255
[TBL] [Abstract][Full Text] [Related]
36. TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival.
Micale L; Fusco C; Fontana A; Barbano R; Augello B; De Nittis P; Copetti M; Pellico MT; Mandriani B; Cocciadiferro D; Parrella P; Fazio VM; Dimitri LM; D'Angelo V; Novielli C; Larizza L; Daga A; Merla G
BMC Cancer; 2015 Jun; 15():470. PubMed ID: 26077989
[TBL] [Abstract][Full Text] [Related]
37. Genomic organization and cytokine-mediated inducibility of the human TRIM-8/Gerp gene.
Toniato E; Flati V; Laglia E; Mincione G; Martinotti S
Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):71-6. PubMed ID: 15345195
[TBL] [Abstract][Full Text] [Related]
38. Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.
Olivos DJ; Mayo LD
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898034
[TBL] [Abstract][Full Text] [Related]
39. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
40. Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue.
Rashi-Elkeles S; Elkon R; Weizman N; Linhart C; Amariglio N; Sternberg G; Rechavi G; Barzilai A; Shamir R; Shiloh Y
Oncogene; 2006 Mar; 25(10):1584-92. PubMed ID: 16314843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
